Literature DB >> 9295828

An evaluation of empiric vs. nomogram-based dosing of heparin in an intensive care unit.

G Brown1, P Dodek.   

Abstract

OBJECTIVE: To compare the time to achieve therapeutic anticoagulation with heparin using two dosing methods.
DESIGN: A retrospective before and after time series.
SETTING: An 11-bed medical-surgical intensive care unit of a tertiary, teaching hospital. PATIENTS: Critically ill patients who required full dose anticoagulation as part of treatment of hemodynamic or respiratory failure. INTERVENTION: The use of a weight-based dosing nomogram with independent adjustment of infusion rates by nursing staff utilizing the nomogram dosing directions. This nomogram was compared with prior empiric heparin dosing by physicians.
MEASUREMENTS AND MAIN RESULTS: The time to achieve a therapeutic activated partial thromboplastin time (PTT) (> 60 secs) was significantly less during use of the nomogram than during use of the empiric dosing method. The number of adjustments required to achieve the therapeutic PTT was less during use of the nomogram. Heparin dosing using the nomogram resulted in larger initial heparin infusion rates (unit/kg) and significantly higher initial PTT results. There was no difference in the initial bolus dose, time to first measured PTT, number of PTT measurements outside the therapeutic range, or signs of toxicity from subtherapeutic or supratherapeutic anticoagulation.
CONCLUSIONS: Use of a weight-based heparin dosing nomogram by intensive care unit nursing staff can shorten the time to achieve therapeutic anticoagulation compared with empiric dosing by physicians.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9295828     DOI: 10.1097/00003246-199709000-00021

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  8 in total

1.  Description and Evaluation of the Implementation of a Weight-Based, Nurse-Driven Heparin Nomogram in a Tertiary Academic Medical Center.

Authors:  James W Schurr; Craig A Stevens; Anne Bane; Carol Luppi; Sarah E Culbreth; Amy Leigh Miller; Jean M Connors; Katelyn W Sylvester
Journal:  Clin Appl Thromb Hemost       Date:  2017-08-04       Impact factor: 2.389

2.  Evaluation of 2 weight-based protocols for administration of heparin.

Authors:  Diana Tsang; Karen F Shalansky; Elaine Lum
Journal:  Can J Hosp Pharm       Date:  2009-11

Review 3.  Enoxaparin. A review of its clinical potential in the management of coronary artery disease.

Authors:  S Noble; C M Spencer
Journal:  Drugs       Date:  1998-08       Impact factor: 9.546

4.  Comparison of Time to Therapeutic aPTT in Patients Who Received Continuous Unfractionated Heparin After Implementation of Pharmacy-wide Intervention Alerts.

Authors:  Duaa Alsulaiman; Katelyn Sylvester; Craig Stevens; Danielle Carter
Journal:  Hosp Pharm       Date:  2016-09

5.  Delivery of optimized inpatient anticoagulation therapy: consensus statement from the anticoagulation forum.

Authors:  Edith A Nutescu; Ann K Wittkowsky; Allison Burnett; Geno J Merli; Jack E Ansell; David A Garcia
Journal:  Ann Pharmacother       Date:  2013-04-12       Impact factor: 3.154

6.  An automated strategy for bedside aPTT determination and unfractionated heparin infusion adjustment in acute coronary syndromes: insights from PARAGON A.

Authors:  L Kristin Newby; Robert A Harrington; Manjushri V Bhapkar; Frans Van de Werf; Judith S Hochman; Christopher B Granger; R John Simes; Catherine G Davis; Eric J Topol; Robert M Califf; David J Moliterno
Journal:  J Thromb Thrombolysis       Date:  2002-08       Impact factor: 2.300

7.  Evaluation of an electronic warfarin nomogram for anticoagulation of hemodialysis patients.

Authors:  Benjamin K A Thomson; Jennifer M MacRae; Lianne Barnieh; Jianguo Zhang; Elizabeth MacKay; Megan A Manning; Brenda R Hemmelgarn
Journal:  BMC Nephrol       Date:  2011-09-26       Impact factor: 2.388

8.  Prevention and diagnosis of venous thromboembolism in critically ill patients: a Canadian survey.

Authors:  D Cook; J McMullin; R Hodder; M Heule; J Pinilla; P Dodek; T Stewart
Journal:  Crit Care       Date:  2001-09-26       Impact factor: 9.097

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.